Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies-Reference-Cited by-同舟云学术

Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies

Published:2021-04-25 Issue:3 Volume:11 Page:971-982
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Buhl Timo,Rosmarin David,Serra-Baldrich Esther,Fernandez-Peñas Pablo^ORCID,Igarashi Atsuyuki^ORCID,Konstantinou Maria Polina,Chen Sherry,Lu Na,Pierce Evangeline,Casillas Marta^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00534-8.pdf

Reference23 articles.

1. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73:1284–93.

2. Silverberg JI, Gelfand JM, Margolis DJ, et al. Atopic dermatitis in US adults: from population to health care utilization. J Allergy Clin Immunol Pract. 2019;7:1524–32.

3. Boguniewicz M, Fonacier L, Guttman-Yassky E, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22e2.

4. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32:657–82.

5. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121:340–7.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Janus Kinase Inhibitors in Pediatric Atopic Dermatitis;Current Allergy and Asthma Reports;2024-08-06

2. Baricitinib for Prurigo Nodularis: A Pilot Study on Efficacy and Safety;Dermatologic Therapy;2024-05-07

3. Effects of abrocitinib on pruritus and eczema symptoms and tolerance in patients with moderate‑to‑severe atopic dermatitis in randomized, double‑blind and placebo‑controlled trials: A systematic review and a meta‑analysis;Biomedical Reports;2024-03-29

4. Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores;Journal of the European Academy of Dermatology and Venereology;2023-12-02

5. A detailed evaluation of the effect of dupilumab on sleep in adults with atopic dermatitis;British Journal of Dermatology;2023-09-02